Screener
Boston Scientific BSX Business Segments
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Net sales of reportable segments by Business | ||||||
| Cardiovascular | $3.62B+8.5% | $3.5B+10.9% | $3.47B+16.4% | $3.33B+21.4% | $3.34B+25.4% | |
| MedSurg | $1.82B+6.1% | $1.7B+5.7% | $1.8B+10.1% | $1.71B+15.5% | $1.71B+14.6% |
FAQ
- How does Boston Scientific break its business down?
- Boston Scientific (BSX) reports net sales of reportable segments by business across 2 parts — Cardiovascular and MedSurg. Each is extracted from the segment footnotes and tracked over time.
- Where does Boston Scientific's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Boston Scientific's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
